Minneapolis, MN, United States of America

Adam J Harvey

This inventor holds 4 USPTO granted patents and 4 published patent applications. Top assignees: - Humanetics Corporation, University of Pennsylvania. Active years: 2021-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Adam J Harvey. Retrieved from https://idiyas.com/inventor/adam-j-harvey

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 

% Patents Active = 100.0

Average Co-Inventor Count = 3.7

ph-index = 2

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2021-2025

Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Adam J Harvey

Introduction

Adam J Harvey is a notable inventor based in Minneapolis, MN (US), recognized for his significant contributions to the field of proton radiation therapy. With a total of four patents to his name, Harvey has made strides in enhancing the effectiveness of cancer treatments.

Latest Patents

Among his latest patents, Harvey has developed materials and methods for sensitizing cells to proton radiation. These innovations aim to improve the effectiveness of high linear energy transfer (LET) proton radiation therapy against tumor cells. His work in this area is crucial for advancing cancer treatment methodologies.

Career Highlights

Throughout his career, Adam J Harvey has worked with prominent organizations such as Humanetics Corporation and the University of Pennsylvania. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Some of his notable coworkers include Michael D Kaytor and Keith Cengel. Their collaborative efforts have furthered the development of innovative solutions in proton radiation therapy.

Conclusion

Adam J Harvey's work exemplifies the impact of innovation in medical technology, particularly in cancer treatment. His patents and collaborations highlight his commitment to improving patient outcomes through advanced therapeutic methods.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…